TP53 and neoplasm: To test the effect of R2 on tumor growth in vivo, we subcutaneously injected isogenic HCT116 p53+/+ and HCTp53-/- cells in the same mice into their right and left sides, respectively, and then treated them, with R2 and measured xenograft tumor growth (Figure 6A, upper panels).